APA (7th ed.) Citation

AS, A., V, J., H, M., X, Y., A, R., JS, M., . . . TT, N. (2025). Harnessing Facebook to Investigate Real-World Mentions of Adverse Events of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications: Observational Study of Facebook Posts From 2022 to 2024. JMIR infodemiology, 5, e73619. https://doi.org/10.2196/73619

Chicago Style (17th ed.) Citation

AS, Alibilli, et al. "Harnessing Facebook to Investigate Real-World Mentions of Adverse Events of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications: Observational Study of Facebook Posts From 2022 to 2024." JMIR Infodemiology 5 (2025): e73619. https://doi.org/10.2196/73619.

MLA (9th ed.) Citation

AS, Alibilli, et al. "Harnessing Facebook to Investigate Real-World Mentions of Adverse Events of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications: Observational Study of Facebook Posts From 2022 to 2024." JMIR Infodemiology, vol. 5, 2025, p. e73619, https://doi.org/10.2196/73619.